ALAMEDA, Calif. , July 7, 2026 /PRNewswire/ -- Penumbra, Inc . (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world...
The THUNDERBOLT TM Computer Assisted Vacuum Thrombectomy (CAVT TM ) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid,...
THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal
ALAMEDA, Calif. , May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.
Barchart Research What to Expect from PEN Earnings PEN Generated May 5, 2026 Current Price $323.86 EPS Estimate $$1.11 Consensus Rating Hold Average Move 8.04% Penumbra's First Quarter Without Guidance...
Barchart Research What to Expect from PEN Earnings PEN Generated April 28, 2026 Current Price $325.99 EPS Estimate $$1.11 Consensus Rating Hold Average Move 8.04% Penumbra's Thrombectomy Momentum: The...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Penumbra , Inc....